Subodh Verma

650 total citations · 4 hit papers
13 papers, 277 citations indexed

About

Subodh Verma is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Subodh Verma has authored 13 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 1 paper in Surgery. Recurrent topics in Subodh Verma's work include Diabetes Treatment and Management (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Heart Failure Treatment and Management (7 papers). Subodh Verma is often cited by papers focused on Diabetes Treatment and Management (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Heart Failure Treatment and Management (7 papers). Subodh Verma collaborates with scholars based in Canada, United States and United Kingdom. Subodh Verma's co-authors include Javed Butler, Dalane W. Kitzman, Mark C. Petrie, Melanie J. Davies, Barry A. Borlaug, Mikhail Kosiborod, Sanjiv J. Shah, Cecilia Rönnbäck, Søren Rasmussen and Steven E. Kahn and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Subodh Verma

11 papers receiving 268 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

2024 123 citations Mikhail Kosiborod, John Deanfield et al. The Lancet profile →
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials

2024 43 citations Sanjiv J Shah, Kavita Sharma et al. European Heart Journal profile →
Inflammation in Obesity-Related HFpEF

2024 41 citations Subodh Verma, Mark C. Petrie et al. Journal of the American College of Cardiology profile →
Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial

2025 16 citations Kausik K. Ray, Robert S. Rosenson et al. The Lancet profile →

Peers

Countries citing papers authored by Subodh Verma

Since Specialization

Citations

This map shows the geographic impact of Subodh Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subodh Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subodh Verma more than expected).

Fields of papers citing papers by Subodh Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subodh Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subodh Verma. The network helps show where Subodh Verma may publish in the future.

Co-authorship network of co-authors of Subodh Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Subodh Verma. A scholar is included among the top collaborators of Subodh Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subodh Verma. Subodh Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial breakdown → 2025 ·The Lancet ·Kausik K. Ray, (unknown), Robert S. Rosenson, Jeremiah Jones, Xiaosu Ma, Jennie Walgren, Axel Haupt, Subodh Verma, Daniel Gaudet, Stephen J. Nicholls, Giacomo Ruotolo	16
2	EFFECT OF THE GLP-1 RECEPTOR AGONIST SEMAGLUTIDE ON TOTAL CARDIOVASCULAR EVENTS IN PATIENTS WITH CARDIOVASCULAR DISEASE AND OVERWEIGHT OR OBESITY BUT NO DIABETES IN THE SELECT TRIAL 2025 ·Journal of the American College of Cardiology ·(unknown), Helen M. Colhoun, Scott S. Emerson, G. Kees Hovingh, (unknown), Steven E. Kahn, Ildiko Lingvay, (unknown), Cristóbal Morales, (unknown), (unknown), Benjamin M. Scirica, Francisco J. Tinahones, (unknown), Subodh Verma, Peter Weeke, Donna H. Ryan, John Deanfield	0
3	Contemporary Prevention and Management of Postoperative Delirium in Cardiac Surgery Patients 2025 ·Seminars in Thoracic and Cardiovascular Surgery ·(unknown), (unknown), (unknown), (unknown), Raj Kumar Verma, (unknown), (unknown), (unknown), Jessica Spence, C. David Mazer, Ahmad Alli, Subodh Verma, Rakesh C. Arora	0
4	Atrial Fibrillation and Semaglutide Effects in Obesity-Related Heart Failure With Preserved Ejection Fraction 2024 ·Journal of the American College of Cardiology ·Subodh Verma, Javed Butler, Barry A. Borlaug, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie, Sanjiv J. Shah, Thomas Jensen, Søren Rasmussen, Cecilia Rönnbäck, Béla Merkely, Evan L. O’Keefe, Mikhail Kosiborod	17
5	Inflammation in Obesity-Related HFpEF breakdown → 2024 ·Journal of the American College of Cardiology ·Subodh Verma, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Cecilia Rönnbäck, Steen Z. Abildstrøm, (unknown), Dennis Wolf, Dirk von Lewinski, Małgorzata Lelonek, Vojtěch Melenovský, Michele Senni, Mikhail Kosiborod	41
6	Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials 2024 ·Journal of Cardiac Failure ·Kieran F. Docherty, (unknown), (unknown), Rudolf A. de Boer, Jersey Chen, Ann Hammarstedt, Dalane W. Kitzman, Mikhail Kosiborod, Anna Maria Langkilde, Barry Reicher, Michele Senni, Ulrica Wilderäng, Subodh Verma, Martín Cowie, Scott D. Solomon, John J.V. McMurray	1
7	Development and Validation of a Machine Learning-Based Approach to Identify High-Risk Diabetic Cardiomyopathy Phenotype 2024 ·European Journal of Heart Failure ·Matthew W. Segar, Muhammad Usman, Kershaw V. Patel, Muhammad Shahzeb Khan, (unknown), (unknown), Carolyn S.P. Lam, Subodh Verma, DuWayne L. Willett, David Kao, James L. Januzzi, Ambarish Pandey	2
8	Once-weekly semaglutide in patients with heart failure with preserved ejection fraction, obesity and type 2 diabetes: main results from the STEP-HFpEF DM trial 2024 ·Obesity Research & Clinical Practice ·(unknown), Mikhail Kosiborod, Mark C Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, G. Kees Hovingh, Dalane W Kitzman, Daniél Vega Møller, Marianne Bach Treppendahl, Subodh Verma, Thomas Jensen, (unknown), Marie L.S. Lindegaard, (unknown)	1
9	A Multi-Specialty Delphi Consensus on Assessing and Managing Cardiopulmonary Risk in Patients with COPD 2024 ·International Journal of COPD ·Mohit Bhutani, Jean Bourbeau, Shaun G. Goodman, Nathaniel M. Hawkins, Alan Kaplan, Peter Lin, Erika Penz, Subodh Verma, Shelley Zieroth	1
10	Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients With Heart Failure: An Analysis of the DETERMINE Trials 2024 ·Circulation Heart Failure ·Kieran F. Docherty, (unknown), (unknown), Rudolf A. de Boer, Martín Cowie, Ann Hammarstedt, Dalane W. Kitzman, Mikhail Kosiborod, Anna Maria Langkilde, Barry Reicher, Michele Senni, Sanjiv J. Shah, Subodh Verma, Scott D. Solomon, John J.V. McMurray	3
11	Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials breakdown → 2024 ·The Lancet ·Mikhail Kosiborod, John Deanfield, Richard Pratley, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Scott S. Emerson, Steven E. Kahn, Dalane W. Kitzman, Ildiko Lingvay, Kenneth W. Mahaffey, Mark C. Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, Sanjiv J. Shah, Subodh Verma, Peter Weeke, A. Michael Lincoff	123
12	Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction 2024 ·Journal of the American College of Cardiology ·Morten Schou, Mark C. Petrie, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Subodh Verma, (unknown), Khaja Chinnakondepalli, (unknown), Steen Z. Abildstrøm, (unknown), Mikhail Kosiborod	29
13	Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials breakdown → 2024 ·European Heart Journal ·Sanjiv J Shah, Kavita Sharma, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Mark C. Petrie, Subodh Verma, (unknown), Khaja Chinnakondepalli, (unknown), Thomas Jensen, Søren Rasmussen, Rabea Asleh, Tuvia Ben‐Gal, Mikhail Kosiborod	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact